Table III.
Association between exposure control use during administration of antineoplastic drugs and fecundity among women attempting pregnancy (n=2,649).
n (%) | Median Pregnancy Attempt in Months [IQR] | Unadjusted TR | (95%CI) | Adjusted TR* | (95%CI) | |
---|---|---|---|---|---|---|
Antineoplastic drug administration | ||||||
Never | 1572 (59.3) | 3[1,7] | 1(REF) | - | 1(REF) | - |
Yes, prior to baseline | 786 (29.7) | 3[1,9] | 1.08 | 0.98–1.18 | 1.02 | 0.93–1.12 |
Yes, at baseline | ||||||
Exposure controls not always used | 21 (0.79) | 4 [2,11] | 1.33 | 0.83–2.15 | 1.25 | 0.79–1.96 |
Exposure controls always used | 270 (10.2) | 3[1,8] | 1.00 | 0.87–1.15 | 0.96 | 0.83–1.10 |
Adjusted for age, race, BMI, smoking status, marital status, hours worked per week, frequency of occupational moving or lifting a heavy load, and current exposure to ionizing radiation, high-level disinfectants, anesthetic gases, and aerosolized drugs.
Abbreviations: n, number of nurses; IQR, inter-quartile range; TR, time ratio; REF, reference.